Fluorescent SAM Probes for Methyltransferase Binding Assays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current assays for screening SAM-utilizing methyltransferases lack efficient means to directly measure specific binding interactions of test compounds, often resulting in false positives and requiring radioactive materials, which is inefficient and environmentally hazardous.
Innovation Solution
Development of fluorescent detection analytes, such as sinefungin-based probes, that bind to SAM-utilizing proteins, allowing for the use of fluorescence polarization or TR-FRET assays to measure test compound binding affinity and dissociation constants, providing direct binding information without radioactive waste.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If radioactive materials are used in binding assays, then binding interactions can be measured, but environmental hazard and safety issues increase
Solution Approach 1:
The patent replaces radioactive detection systems with fluorescence-based detection systems. Fluorescently labeled SAM analogs emit light signals when bound to methyltransferases, eliminating the need for radioactive isotopes while maintaining measurement precision for binding affinity and dissociation constant determination
Solution Approach 2:
The invention changes the detection parameter from radioactivity to fluorescence intensity. By using fluorescently labeled S-adenosylmethionine analogs, the assay measures binding through fluorescence polarization or TR-FRET signals, providing a safe alternative that maintains quantitative accuracy for measuring test compound binding to SAM-utilizing proteins
2Measurement precision
If conventional binding assays are used, then binding can be measured, but false positives increase due to indirect measurement methods
Solution Approach 1:
The fluorescently labeled SAM analog directly competes with test compounds for binding to the methyltransferase active site. This direct competitive binding assay allows test compounds to displace the fluorescent probe from the protein, providing reliable measurements of binding affinity without indirect detection steps that cause false positives
Solution Approach 2:
The fluorescently labeled S-adenosylmethionine analog serves as a mediator between the test compound and the methyltransferase. It binds to the protein's SAM binding site, and test compounds compete for this same site, allowing direct measurement of binding interactions through fluorescence signal changes without requiring enzyme activity or indirect detection
3Productivity
If homogeneous assays are used for high-throughput screening, then screening speed increases, but assay complexity increases
Solution Approach 1:
The patent combines the substrate (SAM analog), the target (methyltransferase), and the detection system (fluorescence polarization or TR-FRET) into a single homogeneous assay mixture. This eliminates the need for separate incubation, washing, and detection steps, enabling high-throughput screening while maintaining assay robustness and reducing procedural complexity
Solution Approach 2:
The fluorescently labeled SAM analog serves multiple functions simultaneously: it acts as the substrate analog that binds to the methyltransferase, the fluorescent probe for detection, and the competitive ligand for measuring test compound binding. This multi-functionality simplifies the assay design and enables high-throughput screening across multiple plates and conditions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, homogeneous, and high-throughput screening of compounds binding to SAM-utilizing proteins, reducing false positives and environmental impact while offering precise binding affinity measurements.
Implementation Method 1
fluorescence polarization or TR-FRET assays to measure test compound binding affinity
Implementation Method 2
fluorescence polarization or TR-FRET assays to measure test compound binding affinity
Data Source
AI summary
Assay methods may generally comprise forming homogeneous assay mixtures comprising target SAM-utilizing protein, fluorescent detection analyte, and test compound, incubating, and measuring FP or TR-FRET signal emitted in order to determine a measure of test compound-SAM -utilizing protein binding. Assay mixtures comprise a SAM-utilizing protein, and a fluorescent detection analyte that binds with the SAM-utilizing protein in the absence of test compound. Assay mixtures may further comprise a test compound. Assay mixture embodiments may generate FP or TR-FRET signal properties that are a function of the inherent binding interactions of both the test compound and the detection analyte with the SAM-utilizing protein. Fluorescent detection analytes comprise a fluorophore moiety, a covalent linker moiety, and a SAM-utilizing protein ligand moiety and could be utilized in FP or TR-FRET assays to measure test compound binding.